• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子-α在帕金森病单侧6-羟基多巴胺损伤模型中对左旋多巴诱导的运动障碍的促成作用

Contributive Role of TNF-α to L-DOPA-Induced Dyskinesia in a Unilateral 6-OHDA Lesion Model of Parkinson's Disease.

作者信息

Dos Santos Pereira Maurício, Abreu Gabriel Henrique Dias, Rocca Jeremy, Hamadat Sabah, Raisman-Vozari Rita, Michel Patrick Pierre, Del Bel Elaine

机构信息

Department of Basic and Oral Biology, FORP, Campus USP, University of São Paulo, Ribeirão Preto, Brazil.

Department of Physiology, FMRP, Campus USP, University of São Paulo, Ribeirão Preto, Brazil.

出版信息

Front Pharmacol. 2021 Jan 11;11:617085. doi: 10.3389/fphar.2020.617085. eCollection 2020.

DOI:10.3389/fphar.2020.617085
PMID:33510643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836015/
Abstract

Our present objective was to better characterize the mechanisms that regulate striatal neuroinflammation in mice developing L-DOPA-induced dyskinesia (LID). For that, we used 6-hydroxydopamine (6-OHDA)-lesioned mice rendered dyskinetic by repeated intraperitoneal injections of 3,4-dihydroxyphenyl-L-alanine (L-DOPA) and quantified ensuing neuroinflammatory changes in the dopamine-denervated dorsal striatum. LID development was associated with a prominent astrocytic response, and a more moderate microglial cell reaction restricted to this striatal area. The glial response was associated with elevations in two pro-inflammatory cytokines, tumor necrosis factor-α (TNF-α) and interleukin-1β. Treatment with the phytocannabinoid cannabidiol and the transient receptor potential vanilloid-1 (TRPV-1) channel antagonist capsazepine diminished LID intensity and decreased TNF-α levels without impacting other inflammation markers. To possibly reproduce the neuroinflammatory component of LID, we exposed astrocyte and microglial cells in culture to candidate molecules that might operate as inflammatory cues during LID development, i.e., L-DOPA, dopamine, or glutamate. Neither L-DOPA nor dopamine produced an inflammatory response in glial cell cultures. However, glutamate enhanced TNF-α secretion and GFAP expression in astrocyte cultures and promoted Iba-1 expression in microglial cultures. Of interest, the antidyskinetic treatment with cannabidiol + capsazepine reduced TNF-α release in glutamate-activated astrocytes. TNF-α, on its own, promoted the synaptic release of glutamate in cortical neuronal cultures, whereas cannabidiol + capsazepine prevented this effect. Therefore, we may assume that the release of TNF-α by glutamate-activated astrocytes may contribute to LID by exacerbating corticostriatal glutamatergic inputs excitability and maintaining astrocytes in an activated state through a self-reinforcing mechanism.

摘要

我们目前的目标是更好地描述在发生左旋多巴诱导的异动症(LID)的小鼠中调节纹状体神经炎症的机制。为此,我们使用了6-羟基多巴胺(6-OHDA)损伤的小鼠,通过反复腹腔注射3,4-二羟基苯丙氨酸(L-DOPA)使其出现异动症,并对多巴胺去神经支配的背侧纹状体中随之发生的神经炎症变化进行定量分析。LID的发展与显著的星形胶质细胞反应相关,以及局限于该纹状体区域的更适度的小胶质细胞反应。胶质细胞反应与两种促炎细胞因子肿瘤坏死因子-α(TNF-α)和白细胞介素-1β的升高有关。用植物大麻素大麻二酚和瞬时受体电位香草酸受体1(TRPV-1)通道拮抗剂辣椒素治疗可降低LID强度并降低TNF-α水平,而不影响其他炎症标志物。为了可能重现LID的神经炎症成分,我们将培养的星形胶质细胞和小胶质细胞暴露于可能在LID发展过程中作为炎症信号的候选分子,即L-DOPA、多巴胺或谷氨酸。L-DOPA和多巴胺在胶质细胞培养物中均未产生炎症反应。然而,谷氨酸增强了星形胶质细胞培养物中TNF-α的分泌和胶质纤维酸性蛋白(GFAP)的表达,并促进了小胶质细胞培养物中离子钙接头蛋白1(Iba-1)的表达。有趣的是,大麻二酚+辣椒素的抗异动症治疗降低了谷氨酸激活的星形胶质细胞中TNF-α的释放。TNF-α本身促进了皮质神经元培养物中谷氨酸的突触释放,而大麻二酚+辣椒素可阻止这种作用。因此,我们可以假设谷氨酸激活的星形胶质细胞释放TNF-α可能通过加剧皮质纹状体谷氨酸能输入的兴奋性并通过自我强化机制使星形胶质细胞维持在激活状态而导致LID。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/753754b165bb/fphar-11-617085-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/5fbe7e31f480/fphar-11-617085-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/2ad9f958fa7a/fphar-11-617085-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/7554dedb52fe/fphar-11-617085-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/4b66262fd009/fphar-11-617085-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/3accf026e1d1/fphar-11-617085-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/fbe1298fb0c0/fphar-11-617085-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/d0feedbc814a/fphar-11-617085-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/9198251bd858/fphar-11-617085-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/b74b59eaf76a/fphar-11-617085-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/753754b165bb/fphar-11-617085-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/5fbe7e31f480/fphar-11-617085-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/2ad9f958fa7a/fphar-11-617085-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/7554dedb52fe/fphar-11-617085-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/4b66262fd009/fphar-11-617085-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/3accf026e1d1/fphar-11-617085-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/fbe1298fb0c0/fphar-11-617085-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/d0feedbc814a/fphar-11-617085-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/9198251bd858/fphar-11-617085-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/b74b59eaf76a/fphar-11-617085-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/7836015/753754b165bb/fphar-11-617085-g010.jpg

相似文献

1
Contributive Role of TNF-α to L-DOPA-Induced Dyskinesia in a Unilateral 6-OHDA Lesion Model of Parkinson's Disease.肿瘤坏死因子-α在帕金森病单侧6-羟基多巴胺损伤模型中对左旋多巴诱导的运动障碍的促成作用
Front Pharmacol. 2021 Jan 11;11:617085. doi: 10.3389/fphar.2020.617085. eCollection 2020.
2
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease.脉冲式与连续左旋多巴给药对帕金森病 6-OHDA 模型异动症和神经炎症的差异诱导。
Exp Neurol. 2016 Dec;286:83-92. doi: 10.1016/j.expneurol.2016.09.013. Epub 2016 Sep 30.
3
4'-fluorocannabidiol associated with capsazepine restrains L-DOPA-induced dyskinesia in hemiparkinsonian mice: Contribution of anti-inflammatory and anti-glutamatergic mechanisms.4'-氟麻古醇与辣椒素联合使用可抑制半帕金森病小鼠的 L-DOPA 诱导的运动障碍:抗炎和抗谷氨酸能机制的贡献。
Neuropharmacology. 2024 Jun 15;251:109926. doi: 10.1016/j.neuropharm.2024.109926. Epub 2024 Mar 28.
4
Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function.左旋多巴诱导异动症中的神经炎症:超越免疫功能。
J Neural Transm (Vienna). 2018 Aug;125(8):1287-1297. doi: 10.1007/s00702-018-1874-4. Epub 2018 Mar 14.
5
Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia.抑制BET蛋白功能可抑制6-羟基多巴胺损伤的左旋多巴诱导的异动症大鼠模型中经典NF-κB信号通路的过度激活。
Front Neurosci. 2022 Jun 21;16:896322. doi: 10.3389/fnins.2022.896322. eCollection 2022.
6
Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia.帕金森病 6-OHDA 损伤模型和 L-DOPA 诱导异动症大鼠中 AMPA 受体亚基的可变剪接。
Exp Neurol. 2013 Sep;247:476-84. doi: 10.1016/j.expneurol.2013.01.019. Epub 2013 Jan 27.
7
Systemic Inflammation Increases the Susceptibility to Levodopa-Induced Dyskinesia in 6-OHDA Lesioned Rats by Targeting the NR2B-Medicated PKC/MEK/ERK Pathway.全身炎症通过靶向NR2B介导的PKC/MEK/ERK信号通路增加6-OHDA损伤大鼠对左旋多巴诱导的运动障碍的易感性。
Front Aging Neurosci. 2021 Feb 1;12:625166. doi: 10.3389/fnagi.2020.625166. eCollection 2020.
8
Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.重复给予左旋多巴、溴隐亭或利苏瑞ide对6-羟基多巴胺损伤大鼠纹状体中前脑啡肽原-A和前脑啡肽原-B mRNA水平的影响。
Exp Neurol. 1999 Feb;155(2):204-20. doi: 10.1006/exnr.1998.6996.
9
5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model.5-羟色氨酸治疗左旋多巴诱导的帕金森病大鼠模型运动障碍。
Neurobiol Dis. 2013 Dec;60:108-14. doi: 10.1016/j.nbd.2013.08.014. Epub 2013 Sep 1.
10
Treadmill Exercise Attenuates L-DOPA-Induced Dyskinesia and Increases Striatal Levels of Glial Cell-Derived Neurotrophic Factor (GDNF) in Hemiparkinsonian Mice. treadmill 运动可减轻 L-DOPA 诱导的异动症并增加半帕金森病小鼠纹状体胶质细胞源性神经营养因子 (GDNF)水平。
Mol Neurobiol. 2019 Apr;56(4):2944-2951. doi: 10.1007/s12035-018-1278-3. Epub 2018 Aug 2.

引用本文的文献

1
Uric Acid, the End-Product of Purine Metabolism, Mitigates Tau-Related Abnormalities: Comparison with DOT, a Non-Antibiotic Oxytetracycline Derivative.尿酸,嘌呤代谢的终产物,可减轻与tau相关的异常:与非抗生素土霉素衍生物DOT的比较。
Biomolecules. 2025 Jun 28;15(7):941. doi: 10.3390/biom15070941.
2
Parkinson's disease models and death signaling: what do we know until now?帕金森病模型与死亡信号传导:截至目前我们了解到了什么?
Front Neuroanat. 2024 Oct 29;18:1419108. doi: 10.3389/fnana.2024.1419108. eCollection 2024.
3
CBD's potential impact on Parkinson's disease: An updated overview.

本文引用的文献

1
Striatal Kir2 K+ channel inhibition mediates the antidyskinetic effects of amantadine.纹状体Kir2钾离子通道抑制介导金刚烷胺的抗运动障碍作用。
J Clin Invest. 2020 May 1;130(5):2593-2601. doi: 10.1172/JCI133398.
2
Short and long TNF-alpha exposure recapitulates canonical astrogliosis events in human-induced pluripotent stem cells-derived astrocytes.短期和长期暴露于肿瘤坏死因子-α可重现人诱导多能干细胞衍生星形胶质细胞中的典型星形胶质细胞增生事件。
Glia. 2020 Jul;68(7):1396-1409. doi: 10.1002/glia.23786. Epub 2020 Jan 31.
3
Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption.
大麻二酚对帕金森病的潜在影响:最新综述。
Open Med (Wars). 2024 Oct 28;19(1):20241075. doi: 10.1515/med-2024-1075. eCollection 2024.
4
4'-fluorocannabidiol associated with capsazepine restrains L-DOPA-induced dyskinesia in hemiparkinsonian mice: Contribution of anti-inflammatory and anti-glutamatergic mechanisms.4'-氟麻古醇与辣椒素联合使用可抑制半帕金森病小鼠的 L-DOPA 诱导的运动障碍:抗炎和抗谷氨酸能机制的贡献。
Neuropharmacology. 2024 Jun 15;251:109926. doi: 10.1016/j.neuropharm.2024.109926. Epub 2024 Mar 28.
5
Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation.左旋多巴诱导的运动障碍:N-甲基-D-天冬氨酸受体与神经炎症的相互作用。
Front Immunol. 2023 Oct 4;14:1253273. doi: 10.3389/fimmu.2023.1253273. eCollection 2023.
6
Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study.多西环素治疗帕金森病左旋多巴诱导的运动障碍:初步研究。
Arq Neuropsiquiatr. 2023 May;81(5):460-468. doi: 10.1055/s-0043-1768668. Epub 2023 May 31.
7
Rescue of Dopamine Neurons from Iron-Dependent Ferroptosis by Doxycycline and Demeclocycline and Their Non-Antibiotic Derivatives.强力霉素和去甲金霉素及其非抗生素衍生物对铁依赖性铁死亡多巴胺神经元的挽救作用
Antioxidants (Basel). 2023 Feb 24;12(3):575. doi: 10.3390/antiox12030575.
8
Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model.在半帕金森病小鼠模型中,强力霉素通过抗炎作用减轻左旋多巴诱导的运动障碍。
Front Pharmacol. 2022 Nov 23;13:1045465. doi: 10.3389/fphar.2022.1045465. eCollection 2022.
9
Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia.抑制BET蛋白功能可抑制6-羟基多巴胺损伤的左旋多巴诱导的异动症大鼠模型中经典NF-κB信号通路的过度激活。
Front Neurosci. 2022 Jun 21;16:896322. doi: 10.3389/fnins.2022.896322. eCollection 2022.
10
Modelling α-Synuclein Aggregation and Neurodegeneration with Fibril Seeds in Primary Cultures of Mouse Dopaminergic Neurons.用原纤维种子在原代培养的小鼠多巴胺能神经元中模拟 α-突触核蛋白聚集和神经退行性变。
Cells. 2022 May 13;11(10):1640. doi: 10.3390/cells11101640.
大麻二酚通过抑制 ROS/NF-κB 依赖性信号通路和葡萄糖消耗来预防脂多糖诱导的小胶质细胞炎症。
Glia. 2020 Mar;68(3):561-573. doi: 10.1002/glia.23738. Epub 2019 Oct 24.
4
Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.大麻二酚和大麻素化合物作为治疗帕金森病和左旋多巴诱导运动障碍的潜在策略。
Neurotox Res. 2020 Jan;37(1):12-29. doi: 10.1007/s12640-019-00109-8. Epub 2019 Oct 22.
5
Therapeutic Effect of Modulating TREM-1 via Anti-inflammation and Autophagy in Parkinson's Disease.通过抗炎和自噬调节触发受体表达分子-1对帕金森病的治疗作用
Front Neurosci. 2019 Aug 2;13:769. doi: 10.3389/fnins.2019.00769. eCollection 2019.
6
Microglial glutamate release evoked by α-synuclein aggregates is prevented by dopamine.α-突触核蛋白聚集物诱发的小胶质细胞谷氨酸释放可被多巴胺所阻断。
Glia. 2018 Nov;66(11):2353-2365. doi: 10.1002/glia.23472. Epub 2018 Nov 5.
7
Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors.大麻二酚通过 PPARγ 受体预防氟哌啶醇诱导的小鼠空嚼运动和炎症变化。
Brain Behav Immun. 2018 Nov;74:241-251. doi: 10.1016/j.bbi.2018.09.014. Epub 2018 Sep 11.
8
Inhaling xenon ameliorates l-dopa-induced dyskinesia in experimental parkinsonism.吸入氙气可改善实验性帕金森病中 l-多巴诱导的运动障碍。
Mov Disord. 2018 Oct;33(10):1632-1642. doi: 10.1002/mds.27404. Epub 2018 May 14.
9
Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function.左旋多巴诱导异动症中的神经炎症:超越免疫功能。
J Neural Transm (Vienna). 2018 Aug;125(8):1287-1297. doi: 10.1007/s00702-018-1874-4. Epub 2018 Mar 14.
10
Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia.金刚烷胺治疗 L-DOPA 诱导的运动障碍的疗效和安全性。
J Neural Transm (Vienna). 2018 Aug;125(8):1237-1250. doi: 10.1007/s00702-018-1869-1. Epub 2018 Mar 7.